Patients with pulmonary arterial hypertension (PAH) can develop several complications with the progression of the disease or as a result of hemodynamic imbalance. Some of these complications include ...

This fundamental research conducted a molecular comparison between smooth muscle cells and adjacent fibroblast cells within lung blood vessels affected by pulmonary arterial hypertension. The study ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ..

when associated with pulmonary embolism (PE). There is a high prevalence of hyperhomocysteinemia in arterial and venous occlusive disease. Hence, in all patients with vascular occlusive disease ...

Pulmonary arterial hypertension (PAH ... In some cases, the cause of PAH is unclear, or it is caused by heart or lung diseases or by certain drugs and infections. About half of PAH cases have ...

A new study published in The New England Journal of Medicine showed that for high-risk patients with pulmonary arterial ...

Pulmonary arterial hypertension (PAH ... "Sotatercept gives us the opportunity to control the disease in a completely new way—even in patients who were previously considered untreatable despite ...

Heart failure related to PAH is becoming more common, with patients living fewer years in full health, a trend that’s ...

Patients with congenital heart disease associated PAH tend to have ... FC: Functional class; iPAH: Idiopathic pulmonary arterial hypertension; iv.: Intravenous; NYHA: New York Heart Association ...